Quarterly Institutional Activity in NVCN

Shares Bought
Shares Sold
View Transactions

Top Institutions Holding NVCN

View all

Latest Institutional Activity in NVCN

Top Purchases

Q1 2023
Tudor Investment Corp Et Al Shares Held: 186K ($0)
Q1 2023
Black Maple Capital Management LP Shares Held: 108K ($0)
Q1 2023
Yakira Capital Management, Inc. Shares Held: 37.4K ($0)
Q1 2023
Mmcap International Inc. Spc Shares Held: 27.7K ($0)
Q1 2023
Sio Capital Management, LLC Shares Held: 22.5K ($0)

Top Sells

Q2 2023
Td Waterhouse Canada Inc. Shares Held: 0 ($0)
Q1 2023
Ubs Group Ag Shares Held: 590 ($0)
Q1 2023
Morgan Stanley Shares Held: 3K ($0)
Q4 2022
Jpmorgan Chase & CO Shares Held: 399 ($0)
Q4 2022
Bank Of America Corp Shares Held: 2.7K ($0)

About NVCN

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.


Insider Transactions at NVCN

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on NVCN

Follow NEOVASC INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVCN shares.

Notify only if

Insider Trading

Get notified when an Neovasc Inc insider buys or sells NVCN shares.

Notify only if

News

Receive news related to NEOVASC INC

Track Activities on NVCN